Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2017

Open Access 01-11-2017 | Original Article

Rigor of non-dairy galactose restriction in early childhood, measured by retrospective survey, does not associate with severity of five long-term outcomes quantified in 231 children and adults with classic galactosemia

Authors: Allison B. Frederick, David J. Cutler, Judith L. Fridovich-Keil

Published in: Journal of Inherited Metabolic Disease | Issue 6/2017

Login to get access

Abstract

One of many vexing decisions faced by parents of an infant with classic galactosemia (CG) is how carefully to restrict non-dairy galactose from their growing child’s diet. Until recently, many experts recommended vigorous lifelong dietary restriction of milk and all high-galactose dairy products as well as some non-dairy sources of galactose such as legumes and specific fruits and vegetables. Recently, experts have begun to relax their recommendations. The new recommendations, that restrict only high galactose dairy products, were made in the face of uncertainty, however, because no sufficiently powered study had been reported testing for possible association between rigor of non-dairy galactose restriction and severity of long-term outcomes in CG. Here we describe the largest study of diet and outcomes in CG reported to date, conducted using information gathered from 231 patients with CG and 71 unaffected sibling controls. We compared rigor of dietary galactose restriction, measured using a 4-point scale by a retrospective parent-response survey, with outcomes including growth, adaptive behaviors, receipt of speech therapy, receipt of special educational services, and for girls and women, a plasma marker of ovarian function (AMH). Our results confirmed the expected differences between patients and controls, but among patients showed no significant association between rigor of non-dairy galactose restriction in early childhood and any of the outcomes quantified. Indeed, some weak associations were seen suggesting that rigorous restriction of non-dairy galactose may be deleterious rather than beneficial. Despite limitations, these findings support the ongoing trend toward diet liberalization with regard to non-dairy sources of galactose for children and adults with classic galactosemia.
Appendix
Available only for authorised users
Literature
go back to reference Acosta P, Yannicelli S (2001) Protocol 14 - Galactosemia, nutritional support protocols, 4th edn. Ross Products Division, Abbott Laboratories, Columbus, OH, pp 262–278 Acosta P, Yannicelli S (2001) Protocol 14 - Galactosemia, nutritional support protocols, 4th edn. Ross Products Division, Abbott Laboratories, Columbus, OH, pp 262–278
go back to reference Acosta PB, Gross KC (1995) Hidden sources of galactose in the environment. Eur J Pediatr 154(7 Suppl 2):S87–S92 Acosta PB, Gross KC (1995) Hidden sources of galactose in the environment. Eur J Pediatr 154(7 Suppl 2):S87–S92
go back to reference Berry G (2014) Classic Galactosemia and clinical variant Galactosemia. In: Pagon R, Adam M, Ardinger H, Bird T, Dolan C, Fong C, Smith R, Stephens K (eds) GeneReviews®. University of Washington, Seattle Berry G (2014) Classic Galactosemia and clinical variant Galactosemia. In: Pagon R, Adam M, Ardinger H, Bird T, Dolan C, Fong C, Smith R, Stephens K (eds) GeneReviews®. University of Washington, Seattle
go back to reference Berry GT, Nissim I, Lin ZP, Mazur AT, Gibson JB, Segal S (1995) Endogenous synthesis of galactose in normal men and patients with hereditary galactosemia. Lancet 346(8982):1073–1074. doi:10.1016/S0140-6736(95)91745-4 Berry GT, Nissim I, Lin ZP, Mazur AT, Gibson JB, Segal S (1995) Endogenous synthesis of galactose in normal men and patients with hereditary galactosemia. Lancet 346(8982):1073–1074. doi:10.​1016/​S0140-6736(95)91745-4
go back to reference CDC (2012) CDC grand rounds: newborn screening and improved outcomes morbidity and mortality weekly report (MMWR), vol 61. Centers for Disease Control and Prevention, Atlanta, GA, pp 390–393 CDC (2012) CDC grand rounds: newborn screening and improved outcomes morbidity and mortality weekly report (MMWR), vol 61. Centers for Disease Control and Prevention, Atlanta, GA, pp 390–393
go back to reference Fridovich-Keil J, Walter J (2008) Galactosemia. In Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, & Ballabio A (Eds.), The Online Metabolic & Molecular Bases of Inherited Disease. McGraw-Hill, New York http://www.ommbid.com/ Fridovich-Keil J, Walter J (2008) Galactosemia. In Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, & Ballabio A (Eds.), The Online Metabolic & Molecular Bases of Inherited Disease. McGraw-Hill, New York http://​www.​ommbid.​com/
go back to reference Gleason L, Rasberry M, Van Calcar S (2010) Understanding Galactosemia: A Diet Guide. In: W. C. Biochemical genetics program, University of Wisconsin-Madison, 3rd Edition edn. Abbot Nutrition and Abbot Laboratories, Columbus, OH Gleason L, Rasberry M, Van Calcar S (2010) Understanding Galactosemia: A Diet Guide. In: W. C. Biochemical genetics program, University of Wisconsin-Madison, 3rd Edition edn. Abbot Nutrition and Abbot Laboratories, Columbus, OH
go back to reference Heinrichs N, Bertram H, Kuschel A, Hahlweg K (2005) Parent recruitment and retention in a universal prevention program for child behavior and emotional problems: barriers to research and program participation. Prev Sci 6(4):275–286. doi:10.1007/s11121-005-0006-1 CrossRefPubMed Heinrichs N, Bertram H, Kuschel A, Hahlweg K (2005) Parent recruitment and retention in a universal prevention program for child behavior and emotional problems: barriers to research and program participation. Prev Sci 6(4):275–286. doi:10.​1007/​s11121-005-0006-1 CrossRefPubMed
go back to reference Isselbacher KJ, Anderson EP, Kurahashi K, Kalckar HM (1956) Congenital galactosemia, a single enzymatic block in galactose metabolism. Science 123(3198):635–636 Isselbacher KJ, Anderson EP, Kurahashi K, Kalckar HM (1956) Congenital galactosemia, a single enzymatic block in galactose metabolism. Science 123(3198):635–636
go back to reference Knerr I, Coss KP, Kratzsch J, Crushell E, Clark A, Doran P et al (2015) Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study. Pediatr Res 78(3):272–279. doi:10.1038/pr.2015.107 CrossRefPubMed Knerr I, Coss KP, Kratzsch J, Crushell E, Clark A, Doran P et al (2015) Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study. Pediatr Res 78(3):272–279. doi:10.​1038/​pr.​2015.​107 CrossRefPubMed
go back to reference Kroes G, Veerman J, De Bruyn E (2003) Bias in parental reports? Maternal psychopathology and the reporting of problem behavior in clinic-referred children. Eur J Psychol Assess 19(3):195–203CrossRef Kroes G, Veerman J, De Bruyn E (2003) Bias in parental reports? Maternal psychopathology and the reporting of problem behavior in clinic-referred children. Eur J Psychol Assess 19(3):195–203CrossRef
go back to reference Pless CE, Pless IB (1995) How well they remember - the accuracy of parent reports. Arch Pediatr Adolesc Med 149(5):553–558 Pless CE, Pless IB (1995) How well they remember - the accuracy of parent reports. Arch Pediatr Adolesc Med 149(5):553–558
go back to reference Riehman K, Crews C, Fridovich-Keil JL (2001) Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. J Biol Chem 276(14):10634–10640. doi:10.1074/jbc.M009583200 CrossRefPubMed Riehman K, Crews C, Fridovich-Keil JL (2001) Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. J Biol Chem 276(14):10634–10640. doi:10.​1074/​jbc.​M009583200 CrossRefPubMed
go back to reference Ryan EL, Lynch ME, Taddeo E, Gleason TJ, Epstein MP, Fridovich-Keil JL (2013) Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia. J Inherit Metab Dis 36(6):1049–1061. doi:10.1007/s10545-012-9575-x CrossRefPubMed Ryan EL, Lynch ME, Taddeo E, Gleason TJ, Epstein MP, Fridovich-Keil JL (2013) Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia. J Inherit Metab Dis 36(6):1049–1061. doi:10.​1007/​s10545-012-9575-x CrossRefPubMed
go back to reference van Calcar S, Bernstein L (2011) Nutrition management of classical and Duarte galactosemia: results from an international survey (abstract). J Inherit Metab Dis 102:262 (Abstract P489) van Calcar S, Bernstein L (2011) Nutrition management of classical and Duarte galactosemia: results from an international survey (abstract). J Inherit Metab Dis 102:262 (Abstract P489)
go back to reference Welling L, Bernstein LE, Berry GT, Burlina AB, Eyskens F, Gautschi M et al (2017) International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis 40(2):171–176. doi:10.1007/s10545-016-9990-5 CrossRefPubMed Welling L, Bernstein LE, Berry GT, Burlina AB, Eyskens F, Gautschi M et al (2017) International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis 40(2):171–176. doi:10.​1007/​s10545-016-9990-5 CrossRefPubMed
Metadata
Title
Rigor of non-dairy galactose restriction in early childhood, measured by retrospective survey, does not associate with severity of five long-term outcomes quantified in 231 children and adults with classic galactosemia
Authors
Allison B. Frederick
David J. Cutler
Judith L. Fridovich-Keil
Publication date
01-11-2017
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2017
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0067-x

Other articles of this Issue 6/2017

Journal of Inherited Metabolic Disease 6/2017 Go to the issue